<?php
/**
 * Forum topic creation script for Avexitide
 * Generated: 2026-11-05 by MinMaxMuscle daily discovery agent
 * Run via WP-CLI or directly on the WordPress host:
 *   php 20261105_avexitide.php
 * Requires: WordPress environment loaded, Asgaros Forum active
 */

// Load WordPress if not already loaded
if ( ! defined( 'ABSPATH' ) ) {
    // Adjust path as needed for your server
    require_once '/var/www/html/wp-load.php';
}

$topic_title   = 'New Research Thread: Avexitide (Exendin 9-39) — GLP-1 Antagonist Phase 3 Data';
$topic_content = '<p><strong>Avexitide</strong> is a 31-amino acid GLP-1 receptor antagonist peptide derived from exendin-4, developed by Amylyx Pharmaceuticals (AMLX) for post-bariatric hypoglycemia (PBH).</p>

<p><strong>Phase 3 LUCIDITY trial topline results (August 2026):</strong></p>
<ul>
<li>55% reduction in composite Level 2+3 hypoglycemic events vs placebo (p=0.000003)</li>
<li>All secondary endpoints met</li>
<li>n=78 adults with PBH after Roux-en-Y gastric bypass</li>
<li>90 mg SC once daily, 16-week treatment period</li>
<li>Mild-to-moderate AEs; no serious AEs related to avexitide</li>
</ul>

<p><strong>What makes this compound interesting for the MinMaxMuscle community:</strong></p>
<p>Avexitide is the pharmacological inverse of semaglutide and tirzepatide — same GLP-1 receptor, opposite action. For people who\'ve had bariatric surgery and suffer from dangerous post-meal hypoglycemia, this would be the first approved pharmaceutical option (NDA planned Q4 2026). It also illustrates the full therapeutic range of GLP-1 biology: agonism for obesity/T2DM, antagonism to prevent the hypoglycemia that can paradoxically result from obesity surgery.</p>

<p>Full data at ObesityWeek 2026: November 15, 2026, San Antonio, TX.</p>

<p>See the full research dossier at <a href="https://minmaxmuscle.com/peptides/avexitide">minmaxmuscle.com/peptides/avexitide</a></p>

<p><em>Research compounds discussed for educational purposes. Not FDA-approved for human use. Consult a healthcare provider before use.</em></p>';

$forum_id = 1; // Adjust to actual forum ID
$author_id = 1; // Adjust to actual admin user ID

// Check if Asgaros Forum is available
if ( function_exists( 'af_add_topic' ) ) {
    $result = af_add_topic( $forum_id, $author_id, $topic_title, $topic_content );
    echo "Topic created: " . ( $result ? "Success (ID: $result)" : "Failed" ) . "\n";
} else {
    // Fallback: create as a regular WP post
    $post_id = wp_insert_post( [
        'post_title'   => $topic_title,
        'post_content' => $topic_content,
        'post_status'  => 'publish',
        'post_author'  => $author_id,
        'post_type'    => 'post',
    ] );
    echo "Fallback post created: " . ( is_wp_error( $post_id ) ? $post_id->get_error_message() : "Success (ID: $post_id)" ) . "\n";
}
